Rigel Pharmaceuticals: Growing Where It Matters
Source: SeekingAlpha
2026-03-10 06:49:37 ET
Topline Summary and Update
It's been quite a long time since my last review of Rigel Pharmaceuticals ( RIGL ), where I was optimistic about the company's performance in light of the growth of their acquired targeted therapies, as well as their own internal pipeline being developed. Since that time, RIGL has seen fairly substantial gains from the market, and they are currently being valued at a price-to-earnings ratio of around 7 (at the time of writing)....
Read the full article on Seeking Alpha
For further details see:
Rigel Pharmaceuticals: Growing Where It Matters
Rigel Pharmaceuticals Inc.
NASDAQ: RIGL
RIGL Trading
-4.51% G/L:
$28.13 Last:
41,488 Volume:
$28.28 Open:
RIGL Latest News
March 03, 2026 04:01:00 pm
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
RIGL Stock Data
$625,132,287
16,430,597
0.07%
54
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
